New Eden - Directors Profiles

Testimonials

Money Matters magazine has named us in its top 50 ‘sound investments’ two years running.

A 2006 Eduwatch survey of postgraduate students placed us in the top 10 of most desirable private sector employers for science graduates.

Since 2003 New Eden’s projects have generated over 1,500 column inches in the national press.

In 2007, a major industry survey conducted by U-Know gave us an ‘excellent’ ranking for our standards of integrity and environmental awareness.

Gull’s Medical Journal voted Lexaran (developed by New Eden) the most significant new medical product of 2005.

DIRECTORS

Dr John Winters

Dr Winters has been Chief Executive Officer at New Eden since 2004, having joined the institute in 1999 from ten highly successful years at MedPlus in California. He is a graduate of St Cedd’s, Cambridge. His background is in Immunology and Antibiotics but he has developed and pursued an interest in cell research in recent years. Several projects along these lines are currently in development.

Dr Kamilla Bergstrom

Dr Bergstrom is our Head of Development. She is renowned within the industry for her transformation of the Limpar Institute in Karlstad, which under her stewardship became classed in the top 25 worldwide. Her speciality is Oncology and since she joined New Eden in 2002 we have established six major new products and have more in development.

Jacqueline Barnes

Ms Barnes is Chief Financial Officer. She was previously Head of International Business and Chief Marketing Officer at Kleinman Bucher Group and helped to launch the Oricon Institute before coming to us. Under Ms Barnes, Kleinman Bucher won two Global Marketing awards.

Dr Leonard Donohue

Dr Donohue is our Head of Research. A graduate of Stone University, Washington State, he has over thirty years of experience in cell research as well as numerous other areas, and joined New Eden in 2005, having previously served as a consultant for during his time at HiveCen in Colorado.